Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.050
-0.040 (-3.67%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $4.56 million as of April 28, 2025. Its market cap has increased by 147.47% in one year.
Market Cap
4.56M
Enterprise Value
-2.22M
1-Year Change
147.47%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $4.56M, a decrease of -97.80%. That is a compound annual growth rate of -74.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 4.56M | -53.33% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |